LORD, ABBETT & CO. LLC - NEUROCRINE BIOSCIENCES INC ownership

NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 45 filers reported holding NEUROCRINE BIOSCIENCES INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
LORD, ABBETT & CO. LLC ownership history of NEUROCRINE BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$6,922
-37.7%
4,666,000
-46.4%
0.03%
-31.6%
Q2 2023$11,119
-6.4%
8,709,000
-1.4%
0.04%
-11.6%
Q1 2023$11,885
-54.8%
8,832,000
-46.8%
0.04%
-54.3%
Q4 2022$26,285
-99.8%
16,612,000
+120.9%
0.09%
+141.0%
Q3 2022$10,627,000
-0.5%
7,521,000
-6.5%
0.04%
+2.6%
Q2 2022$10,680,000
-5.5%
8,045,000
-6.0%
0.04%
+26.7%
Q1 2022$11,303,000
+12.7%
8,563,000
+7.4%
0.03%
+30.4%
Q4 2021$10,025,000
-17.2%
7,976,000
-12.0%
0.02%
-20.7%
Q3 2021$12,105,000
-59.3%
9,062,000
-59.1%
0.03%
-59.7%
Q2 2021$29,732,000
+11.4%
22,141,000
+12.4%
0.07%
+5.9%
Q1 2021$26,678,000
+251.3%
19,698,000
+259.3%
0.07%
+183.3%
Q3 2020$7,594,000
-63.3%
5,483,000
-55.7%
0.02%
-66.7%
Q2 2020$20,700,000
+52.8%
12,375,000
+17.3%
0.07%
+20.0%
Q1 2020$13,549,000
-55.2%
10,553,000
-46.4%
0.06%
-40.6%
Q4 2019$30,242,000
+70.3%
19,685,000
+52.0%
0.10%
+68.3%
Q3 2019$17,760,000
+138.8%
12,947,000
+129.2%
0.06%
+150.0%
Q2 2019$7,438,000
-3.6%
5,648,000
-0.9%
0.02%
-7.7%
Q1 2019$7,713,000
+19.4%
5,697,000
+5.5%
0.03%
+8.3%
Q4 2018$6,458,000
-79.3%
5,399,000
-70.5%
0.02%
-72.1%
Q3 2018$31,207,000
+3.7%
18,281,000
-12.2%
0.09%
-2.3%
Q2 2018$30,091,00020,814,0000.09%
Other shareholders
NEUROCRINE BIOSCIENCES INC shareholders Q2 2021
NameSharesValueWeighting ↓
III Capital Management 12,500,000$17,262,0003.12%
CSS LLC/IL 24,395,000$33,616,0001.59%
Mint Tower Capital Management B.V. 9,000,000$12,407,0001.46%
Context Partners Fund, L.P. 3,000,000$4,125,0000.90%
Context Capital Management, LLC 3,000,000$4,125,0000.90%
SHENKMAN CAPITAL MANAGEMENT INC 4,258,000$5,971,0000.71%
SSI INVESTMENT MANAGEMENT LLC 5,888,000$8,100,0000.70%
Aequim Alternative Investments LP 3,000,000$4,155,0000.55%
WOLVERINE ASSET MANAGEMENT LLC 32,181,000$44,437,0000.40%
TWO SIGMA SECURITIES, LLC 13,000,000$17,875,0000.36%
View complete list of NEUROCRINE BIOSCIENCES INC shareholders